Alpa Laboratories share news and announcements
NSE: ALPABSE: 532878Pharmaceuticals & BiotechnologySmall Cap
Last close ₹49.29down ₹2.17 (4.22%)BSE ₹49.47
Share price at the NSE close on 23 Oct 2026. Previous close ₹51.46.
52-week range of traded prices to 23 Oct 2026
₹46.10Low, 30 Mar 2026₹93.85High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹104 Cr2,659th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 Jul 2026
- 0.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 Jul 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 14,17675.0% delivered
Alpa Laboratories routine notices
40 filed, newest first.
Oct 2026
Sep 2026
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Oct 2024
Jul 2024
Apr 2024
Jan 2024
Oct 2023
Jul 2023
May 2023
Apr 2023
Jan 2023
Oct 2022
3 Oct · Routine
Jul 2022
1 Jul · Routine
Apr 2022
1 Apr · Routine
Jan 2022
Oct 2021
Jul 2021
Apr 2021
Jan 2021
Oct 2020
Jul 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
May 2016
Feb 2016
4 Feb · Routine
In terms of the Code for Corporate Disclosure Practices and Code of Conduct for Prevention of Insider Trading pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 adopted by the Company, the Company has informed all the concerned persons that the Trading Window of the Company will be closed for Directors/ Employees from February 08, 2016 to February 14, 2016 (both days inclusive) .
Oct 2015
Jul 2015
May 2015
Feb 2015
Nov 2014